Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BMPR1B divergent transcript (BMPR1B-DT, TCONS_00007797) is a predicted long noncoding RNA transcribed from the region near the BMPR1B gene, in a divergent orientation. Long noncoding RNAs (lncRNAs) such as this are a class of RNA molecules longer than 200 nucleotides that do not code for proteins but may have regulatory functions in gene expression. This transcript is not recognized as a receptor, enzyme, or known therapeutic drug target, and there is a lack of functional and disease association data in primary biomedical resources and literature. Its biological function, molecular interactions, and disease involvement are currently unknown.
None established; not a protein, not a classical drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BMPR1B divergent transcript (BMPR1B-DT).